Lesion macrophages are a key target for the antiatherogenic effects of LXR agonists (Q81216829)
Jump to navigation
Jump to search
scientific article published on 01 January 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Lesion macrophages are a key target for the antiatherogenic effects of LXR agonists |
scientific article published on 01 January 2005 |
Statements
Lesion macrophages are a key target for the antiatherogenic effects of LXR agonists (English)
Michelle N Bradley
Peter Tontonoz
1 January 2005